The Scope

All

All Categories
By Zack & Helena on August 9, 2022

Immune effector cell (IEC) therapies, commonly referred as cell therapies, utilize human cells to cause or enhance an immune response against tumor cells. Following remarkable successes with several patients in the early 2010s – most notably, the case of Emily Whitehead, the first pediatric CAR-T patient, who recently celebrated 10 years of being cancer-free – […]

By on July 19, 2022

SAI MedPartners has recently taken on a strategic investment from Northlane Capital Partners.

By on

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Elementum. Lorem ipsum dolor sit amet, consectetur

By on

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Elementum. Lorem ipsum dolor sit amet, consectetur

Connect with us on LinkedIn for up-to-the-minute insights

Scroll to top